CAS 9041-08-1 Heparina Heparin Sodium Enoxaparin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: Enoxaparin
• Name: Heparin Sodium
• CAS: 9041-08-1
• Transport Package: Drum
• Specification: 99%
• Trademark: HS
• Origin: China
• HS Code: 2904201000
• Production Capacity: 100000

Product Description

Product name: Heparin sodium
Other name: SODIUM HEPARIN;SODIUM HEPARINATE;REVIPARIN SODIUM;PORCINE HEPARIN SODIUM;BOVINE HEPARIN SODIUM;HEP, NA, BOVINE;HEP, NA, PORCINE;HEPARIN PORCINE SODIUM SALT
CAS: 9041-08-1
MF: (C12H16NS2Na3)20
MW: 887.04
EINECS: 232-681-7
Melting point: 254-256.5 °C
Storage Temp.: 2-8°C
Heparin sodium salt, used as an anticoagulant, is a mucopolysaccharide substance, is the sodium salt form of glucosamine sulfate extracted from the intestinal mucosa of pigs, cattle, and sheep. It is secreted by mast cells to be naturally presented the blood inside the human bodies. Heparin can prevent platelet aggregation and destruction, inhibit the conversion from fibrinogen to fibrin monomers, inhibit the formation of thromboplastin and fight against the pre-formed thromboplastin, and also prevent the conversion of prothrombin to thrombin and counteract the antithrombin.

Uses:
1. Biochemical studies; used for preventing the conversion of prothrombin into thrombin; has blood anti-thrombosis effect.
2. For the delay and prevention of blood clotting.
3.Heparin sodium salt is a mucopolysaccharides biochemical medicine extracted from porcine small intestinal mucosa with strong anticoagulant activity. Mclcan found it from the liver tissue of dog in the study of the clotting mechanism. Brinkous et al proved that heparin having anticoagulant activity. After the first application of heparin as an anticoagulant in clinical filed, it has drawn worldwide attention. With a strong anticoagulant effect, heparin is the primary choice for prevention and treatment of deep vein thrombosis and other thrombotic diseases.

Function

 

1.The treatment of various diseases concurrent disseminated intravascular coagulation early. 
2. Prevention of arterial and venous thrombosis and pulmonary embolism.
3.Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina (to alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of early reinfarction and infarct extension, reduce mortality). 
4.The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5.thrombolytic therapy as maintenance therapy. 
6.used for the prevention of blood coagulation and blood bank transfusion of blood and other body save anticoagulants.

Items	Specifications	Results
Appearance	White or milk whitecrystalline porder	Qualified
Identification	Must pisitive	Positive
Odor	Characteristicless	Qualified
Colour of solution	Must qualified	Qualified
Related substances	Must qualified	Qualified
Residual Solvent	≤0.5%	Qualified
Acidity or alkalinity(PH)	4.5-7.0	6.0
Absorptivity	137 - 147	145
Optical rotation	-1.27° -1.34°	1.31°
Heavy metals	≤20ppm	<20ppm
Losson drying	≤0.5%	0.35%
Sulphated ash	≤0.1%	0.05%
Assay	99.0-101.0%	99.98%